Clinical Characteristics and Healthcare Resource Utilization for Patients with Mucopolysaccharidosis II (MPS II) in the United States: A Retrospective Chart Review.

Ayodele, Olulade; Müller, Kersten; Setayeshgar, Solmaz; Alexanderian, David; Yee, Karen S

Ayodele, Olulade; Müller, Kersten; Setayeshgar, Solmaz; Alexanderian, David; Yee, Karen S.

Afiliação

Ayodele O; Takeda Development Center, Inc., Lexington, MA.
Müller K; ICON plc, Vancouver, British Columbia, Canada.
Setayeshgar S; ICON plc, Vancouver, British Columbia, Canada.
Alexanderian D; Takeda Development Center, Inc., Lexington, MA.
Yee KS; Takeda Development Center, Inc., Cambridge, MA.

J Health Econ Outcomes Res ; 9(1): 117-127, 2022.

Article em En | MEDLINE | ID: mdl-35620452

Palavras-chave

Hunter syndrome; MPS II; burden of illness; enzyme replacement therapy; healthcare resource utilization; lysosomal storage disease

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Aspecto: Implementation_research Idioma: En Revista: J Health Econ Outcomes Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Marrocos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google